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The HIV-1 Nef Protein Acts as a Connector
with Sorting Pathways in the Golgi
and at the Plasma Membrane
Aram Mangasarian,* Michelangelo Foti,† 1990; Crise and Rose, 1992; Jabbar and Nayak, 1990).
Under the influence of Vpu, a factor encoded only by HIVChristopher Aiken,*§ Daniel Chin,‡
type 1 (HIV-1), the retained CD4 molecules are rapidlyJean-Louis Carpentier,† and Didier Trono*
degraded (Willey et al., 1992). In addition, HIV and SIV*Infectious Disease Laboratory
encode the nef gene product, which induces a dramaticThe Salk Institute for Biological Studies
down-regulation of CD4 from the cell surface (Aiken et10010 North Torrey Pines Road
al., 1994; Anderson et al., 1993; Garcia and Miller, 1991;La Jolla, California 92037
Guy et al., 1987; Mariani and Skowronski, 1993; Rhee†Department of Morphology
and Marsh, 1994). This property is highly conservedCentre Medical Universitaire
among primary alleles of HIV-1 nef (Anderson et al.,1211 Geneva 4
1993; Mariani and Skowronski, 1993) and is also ob-Switzerland
served with nef from a pathogenic clone of SIV (Benson‡Agouron Institute
et al., 1993). It thus likely contributes to the demon-505 Coast Boulevard South
strated importance of this protein for high titer virusLa Jolla, California 92037
replication in vivo and for disease induction (Kestler et
al., 1991; Kirchhoff et al., 1995; Deacon et al., 1995).
HIV-1 Nef is a 206 amino acid cytoplasmic proteinSummary
that is produced in abundance at the earliest stage of
viral expression (Kim et al., 1989; Klotman et al., 1991;The HIV Nef protein down-regulates the cell surface
Robert-Guroff et al., 1990) and associates with mem-expression of CD4 and of MHC I at least in part through
branes through an N-terminal myristate (Franchini et al.,accelerated endocytosis. To investigate further the
1986; Kaminchik et al., 1991). In T lymphoid cells, Nefmechanism of this effect, we created chimeric integral
does not affect the rates of CD4 biosynthesis or matura-membrane proteins comprising the extracellular and
tion, but triggers its rapid endocytosis, followed by lyso-transmembrane regions of CD4 or CD8 and Nef as the
somal degradation (Aiken et al., 1994; Rhee and Marsh,cytoplasmic domain. These fusion molecules could
1994; Schwartz et al., 1995; Luo et al., 1996). The mem-down-modulate CD4 in trans in a dileucine-dependent
brane association of Nef is necessary for this effect. Themanner. Furthermore, in spite of lacking receptor-
study of chimeric integral membrane molecules furtherderived internalization signals, the Nef-containing chi-
demonstrates that 20 membrane-proximal residues ofmeras underwent both Golgi retention and rapid endo-
the CD4 cytoplasmic domain are sufficient to confer Nef
cytosis via clathrin-coated pits. Taken together, these
sensitivity to another membrane protein (Aiken et al.,
data suggest that Nef down-regulates CD4 and proba-
1994). Finally, within this region a dileucine motif, resem-bly MHC I by physically connecting these receptors
bling a sorting signal found in the CD3 g and d chainswith sorting pathways in the Golgi and at the plasma
(Letourneur and Klausner, 1992), is crucial for CD4 re-
membrane.
sponse to Nef (Aiken et al., 1994; Salghetti et al., 1995).
The Nef effect is reminiscent of the accelerated inter-
Introduction nalization of CD4 that is observed when helper T cells
are exposed to phorbol-12-myristate-13-acetate (PMA),
CD4 is a type 1 integral membrane glycoprotein ex- since the latter process is also critically dependent on
pressed on the surface of thymocytes, helper T lympho- the CD4 dileucine motif (Shin et al., 1991). However,
cytes, and macrophages (Maddon et al., 1985, 1986). In PMA acts by inducing the protein kinase C–mediated
conjunction with the lymphoid-specific p56lck tyrosine phosphorylation of serine residues on the CD4 cyto-
kinase bound to its cytoplasmic domain (Barber et al., plasmic domain (Acres et al., 1986; Hoxie et al., 1986,
1989; Rudd et al., 1988; Shaw et al., 1989; Turner et al., 1988), a modification proposed to result in exposure of
1990), CD4 participates in T cell ontogeny and promotes the dileucine motif (Shin et al., 1990, 1991). In contrast,
the activation of mature helper T lymphocytes following CD4 phosphorylation is not necessary for Nef action
antigen recognition by the T cell receptor (TCR) (Miceli (Aiken et al., 1994; Garcia and Miller, 1991).
and Parnes, 1991; Parnes, 1989; Robey and Axel, 1990; In addition to its effect on CD4, Nef down-regulates
Veillette et al., 1989; Weiss, 1993; Zu´n˜iga-Pflu¨cker et al., the surface expression of the major histocompatibility
1991). CD4 also serves as the main receptor for the complex class I (MHC I), albeit with a lower efficiency
primate lentiviruses, the human and simian immunodefi- (Schwartz et al., 1996). However, Nef fails to affect a
ciency viruses (HIV and SIV, respectively). In turn, these number of other receptors, including CD8 (Garcia et
viruses encode several proteins that have profound ef- al., 1993), CD29, CD45RO, the interleukin-2 receptor a
fects on CD4 metabolism. The envelope glycoproteins chain, the transferrin receptor (Schwartz et al., 1993),
of both HIV and SIV retain newly synthesized CD4 mole- ICAM-1, CD38, CD69 (Benson et al., 1993), theepidermal
cules in the endoplasmic reticulum (ER) (Crise et al., growth factor (EGF) receptor (C. A. and D. T., unpub-
lished data), and a CD4–low density lipoprotein receptor
fusion protein (Aiken et al., 1994). Therefore, Nef does§Present address: Department of Microbiology and Immunology,
not stimulate endocytosis in a nonspecific manner, forVanderbilt University School of Medicine, Nashville, Tennessee
37232. instance by modifying some general component of the
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internalization machinery. Instead, three models can be
envisioned to explain Nef-induced CD4 endocytosis.
First, Nef might liberate CD4 from an anchor that pre-
vents the recognition of the receptor by clathrin-coated
pits, specialized regions of the cell surface involved in
endocytosis. In T lymphocytes, p56lck negatively regu-
lates CD4 internalization by associating with the recep-
tor cytoplasmic tail, blocking CD4 migration into the pits
(Pelchen-Matthews et al., 1991, 1992, 1993; Sleckman
et al., 1992). Nef could thus act by simply removing
lck from CD4. Nef-induced CD4 endocytosis is indeed
accompanied by the release of p56lck (Aiken et al., 1994;
Rhee and Marsh, 1994). However, this appears to be
only a secondary phenomenon, since Nef acts in cells
that do not express lck, as well as on truncated CD4
molecules that do not bind the kinase (Aiken et al., 1994;
Salghetti et al., 1995). In another model, Nef could inter-
act with or modify CD4 such that the receptor dileucine
motif becomes accessible to clathrin-coated pits; in es-
sence, Nef would then mimic the consequences of PMA
treatment. Finally, Nef could act as a connector between
CD4 and the cell sorting machinery.
In this work, we present evidence in support of this
last model by demonstrating that Nef can trigger, in cis,
the Golgi retention and the accelerated endocytosis of
chimeric integral membrane protein derivatives devoid
of internalization signals. This indicates that Nef con-
tains motifs that can interact with sorting pathways both
in the Golgi and at the plasma membrane, and suggests
Figure 1. Nef as Part of an Integral Membrane Protein Can Down-that the viral protein down-regulates CD4 and probably
Regulate a CD4-Derived Target in trans
MHC I by acting as a physical bridge between these
(A) Schematic representation of the various molecules used in thesereceptors and the cell trafficking machinery.
experiments. The extracellular, transmembrane (TM), and cyto-
plasmic domains are shown, although not to scale. LL414AA indicates
Results a dileucine to dialanine mutation in the CD4 cytoplasmic domain.
(B) Plasmid vectors encoding the wild-type or dileucine-mutated
CD8–CD4 chimera were transfected in 293 cells, with constructstrans Regulation of a CD4-Derived Target
expressing the truncated 44X molecule, the 44Nef CD4–Nef fusionby a Chimeric Integral Membrane Protein
protein, myristoylated Nef, or a control vector (PL2). Surface levelswith Nef as the Cytoplasmic Domain
of CD8 antigenic determinants were measured 2 days later by flow
Efficient CD4 down-modulation in T lymphoid cells and cytometry. The results are representative of four independent exper-
fibroblasts requires the N-terminal myristoylation of Nef, iments.
presumably because this modification allows targeting
of the viral protein to its putative site of action, mem-
branes (Aiken et al., 1994). To examine whether directing
various constructs, and cell surface levels of CD884 andNef subcellular localization through another mechanism
CD884LL414AA were examined by flow cytometry with awould be equally effective, we constructed a chimeric
CD8-specific antibody (Figure 1B). 44X did not alter theintegral membrane protein, which comprised the extra-
expression of CD884. In contrast, the 44Nef chimeracellular and transmembrane regions of CD4 with Nef
was almost as efficient as wild-type Nefat down-regulat-in place of the cytoplasmic domain (Figure 1A). The
ing the surface levels of CD884. As expected, neitherresulting 44Nef chimera was evaluated for its ability to
form of the viral protein affected expression of thedown-regulate a surface molecule containing the CD4
CD884LL414AA marker. These results thus indicate thatcytoplasmic tail. The effects of myristoylated Nef and a
the anchoring of Nef at the plasma membrane by fusionprotein called 44X, which lacks a cytoplasmic domain,
with the transmembrane domain of a surface receptorwere measured in parallel as controls. Since 44Nef and
can substitute for myristoylation in allowing CD4 trans44X were predicted to induce cell surface expression
regulation.of CD4 antigenic determinants, a CD8–CD4 chimera was
used as the down-regulation target for this experiment.
This protein, called CD884, was obtained by fusing the
cis-Mediated Down-Regulation of a Nef-Containingextracellular and transmembrane regions of CD8 to the
Chimeric Integral Membrane ProteinCD4 cytoplasmic tail (Figure 1A). The CD884 molecule
During these experiments, it was noticed that the cellhas previously been shown to be Nef responsive (Aiken
surface levels of the 44Nef chimera were significantlyet al., 1994). The Nef-resistant CD884LL414AA molecule,
lower than those of the tail-less 44X molecule (data notwhose CD4-derived cytoplasmic domain contains a mu-
shown). To investigate this point further, these proteinstated dileucine motif (Figure 1A), served as control. Hu-
man fibroblastic 293 cells were transfected with these were stably produced in Namalwa B lymphoid cells.
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Figure 2. Nef Can Down-Regulate CD4 in cis
Namalwa B lymphoid cell lines were stably
transfected with vectors producing wild-type
CD4 or a CD4 molecule with a double leucine
to alanine mutation in the cytoplasmic do-
main (CD4LL414AA), with or without Nef, as well
as a tail-less CD4 (44X) or the 44Nef CD4–Nef
chimera.
(A) Total levels of the various markers were
determined by Western blotting of cyto-
plasmic extracts with a CD4-specific anti-
body. Lane1, negative control (emptyvector);
lane 2, 44Nef; lane 3, 44X; lane 4, CD4; lane
5, CD4 plus Nef; lane 6, CD4LL414AA; lane 7,
CD4LL414AA plus Nef.
(B) Surface levels of CD4 antigen were evalu-
ated by flow cytometry, and are represented
by the shaded areas. The control corre-
sponds to cells transfected with an empty
vector.
Cell lines expressing wild-type CD4 and the dileucine- molecule through the biosynthetic pathway was im-
mutated CD4LL414AA molecule (Figure 1A) were also es- paired. To test this hypothesis, the kinetics of synthesis
tablished to serve as controls, with or without Nef pro- and degradation of CD4, with or without Nef, as well as
vided in trans. Steady-state amounts of CD4 and its those of 44X and of 44Nef were examined (Figure 3).
derivatives were examined first (Figure 2A). Levels of Cells were pulse labeled with [35S]amino acids, and ex-
the 44Nef chimera and of wild-type CD4 in nef-express- tracts harvested at given timepoints were immunopre-
ing cells were slightly lower than those of CD4 in control cipitated with an anti-CD4 monoclonal antibody. The
cells. By comparison, 44X and CD4LL414AA were more resulting immune complexes were analyzed by gel elec-
abundant, and Nef production did not affect the dileu- trophoresis and autoradiography, with or without prior
cine-mutated CD4 variant. These cell lines were then treatment with endoglycosidase H (endo H). Endo H
analyzed by flow cytometry with anti-CD4 antibody to is an enzyme that hydrolyzes N-linked high mannose
evaluate the cell surface levels of the various molecules oligosaccharides that are cotranslationally added to gly-
(Figure 2B). The truncated 44X molecule was expressed coproteins such as CD4 in the ER. As CD4 traverses the
to high levels. As expected, Nef down-regulated wild- Golgi, complex oligosaccharides are added, which are
type CD4, but did not affect the dileucine-mutated vari- not cleaved by endo H. This study revealed similar rates
ant. Finally, the cell surface expression of the 44Nef of biosynthesis for 44Nef, CD4, and 44X. The maturation
protein was the lowest of all, suggesting that Nef can profiles of CD4 (with and without Nef) and of 44Nef were
down-regulate an integral membrane protein in cis. also comparable, with the majority of both molecules
resistant to endo H by the 2 hr timepoint. Finally, 44X
exhibited a slower rate of maturation, probably becauseA Combination of Intracellular Retention
the absence of a cytoplasmic tail precluded the effi-and Accelerated Endocytosis Accounts
cient transport of this molecule from the ER to the cellfor Nef Action
surface.A plausible explanation for the low cell surface expres-
sion of the 44Nef chimera was that the transport of this To investigate further the mechanism of the trans and
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Figure 3. cis and trans Effects of Nef on CD4 Synthesis and Matu-
ration
Cells were pulse labeled with [35S]amino acids for 30 min, and cyto-
plasmic extracts prepared at the indicated timepoints were analyzed
by immunoprecipitation with anti-CD4 monoclonal antibody, and
subsequently treated with endo H. Endo H–resistant (r) and endo
H–sensitive (s) forms of the molecules are indicated.
cis effects of Nef, we performed a pulse–chase biotinyla-
tion analysis, examining the cell surface trafficking of
CD4 in the presence and absence of Nef, as well as that
of 44Nef and 44X (Figure 4). Cells were pulse labeled
with [35S]amino acids, and surface proteins were biotin-
ylated at the time of sample harvest. After lysis, a first
immunoprecipitation was performed with CD4-specific
Figure 4. Intracellular Retention and Decreased Surface Half-Lifeantibodies to monitor CD4 biosynthesis. A fraction of the
of CD4 in the Presence of Nef in cis and in transrecovered immune complexes was then reprecipitated
Namalwa cells stably expressing the indicated molecules were pulsewith streptavidin-linked agarose beads to assess what
labeled with [35S]amino acids for 30 min. At each timepoint duringproportion of the molecules was present at the cell sur-
the chase, cell surface proteins were biotinylated, and lysates wereface. Results were analyzed by SDS–polyacrylamide gel
immunoprecipitated with CD4-specific antibody. One third of the
electrophoresis (SDS–PAGE), followed by autoradiogra- resulting material was directly analyzed by SDS–PAGE and autoradi-
phy and phosphoimager counting. The 12 hr half-life of ography (total [T]), whereas the remainder was first reprecipitated
CD4 in control cells was reduced to less than 4 hr in with streptavidin beads before being subjected to a similar analysis
(surface [S]). The results were analyzed by SDS–PAGE and autoradi-nef-expressing cells. The half-life of the 44Nef chimera
ography (shown here) and quantitated with a phosphoimager (seewas approximately 6 hr, whereas that of 44X exceeded
text).12 hr. As previously observed in T lymphoid cells (Aiken
et al., 1994; Rhee and Marsh, 1994), the stability of CD4
in nef-expressing cells was markedly increased by am- although intracellular sequestration was most pro-
nounced in the context of the CD4–Nef chimera.monium chloride treatment (data not shown), sug-
gesting that Nef directed CD4 to a lysosomal degrada- To confirm the effect of Nef on internalization, we
used a fluorescence-activated cell sorting (FACS)-tive pathway. The fraction of the molecules present at
the cell surface at the various timepoints was also mea- based endocytosis assay (Figure 5). Over the time of
the analysis (20 min), the internalization of 44Xwas negli-sured. At 2 hr after the pulse, 28% of the total number of
CD4 molecules were detected on the surface of control gible, as expected based on its lack of a cytoplasmic
domain. Initial rates of CD4 endocytosis were approxi-cells, contrasting with only 13% in Nef-producing cells.
Most significantly, less than 3% of all labeled 44Nef mately 1.5% per minute in the absence of Nef, with 15%
internalized at 20 min, whereas the internalization ofmolecules were detected on the cell surface at any time-
point, whereas 35% of the 44X molecules migrated to theCD4LL414AA protein proceeded comparativelyslower,
with 7% of the labeled molecules ultimately found insidethis location. Finally, the surface half-life of the various
proteins was evaluated. It was 3–4 hr for CD4 in nef- the cells. Nef greatly increased the rates of endocytosis
of wild-type but not dileucine-mutated CD4, as pre-expressing cells and for the 44Nef chimera, whereas it
exceeded 10 hr for CD4 Nef-negative cells and for 44X. viously described in T lymphoid cells (Aiken et al., 1994).
Finally, the 44Nef chimeric protein underwent internal-Taken together, these data suggested that Nef induced
both the intracellular retention and the accelerated inter- ization at rates that were even higher than those mea-
sured for wild-type CD4 in nef-expressing cells, withnalization of CD4, whether expressed in cis or in trans,
Nef as a Connector with Trafficking Pathways
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Figure 5. A CD4–Nef Chimera Undergoes
Accelerated Endocytosis
Internalization rates of the wild-type and di-
leucine-mutated CD4 molecules, in the ab-
sence and presence of Nef, as well as of the
tail-less 44X variant and of the CD4–Nef
44Nef chimera, were measured using a
FACS-based endocytosis assay. The results
are representativeof four independent exper-
iments.
initial rates greater than 4% per minute quickly resulting Namalwa (CD4) cells with PMA resulted in more than
in more than 40% of the labeled protein migrating inside doubling the rates of CD4 endocytosis, indicating that
the cells. Accelerated rates of endocytosis were also this was not the case (data not shown).
observed when 44Nef was expressed in 293 fibroblastic Taken together, these results indicate that substitut-
cells, indicating that the observed phenomenon was not ing HIV-1 Nef for the cytoplasmic domain of an integral
limited to B lymphoid cells (data not shown). membrane protein is sufficient to direct the resulting
These data indicate that the chimeric 44Nef molecule molecule to the endocytic pathway.
is internalized at a high rate, in spite of lacking CD4-
derived endocytosis motifs. To confirm that the replace- The Endocytosis of CD4–Nef Occurs
ment of the CD4 cytoplasmic tail by Nef was solely via Clathrin-Coated Pits
responsible for this phenomenon, we performed a simi- The above evidence suggested that Nef is capable of
lar analysis on a CD8-derived molecule. This was of interacting with the internalization apparatus. To investi-
particular interest because CD8 is a T cellsurface marker gate this issue further, we examined the cell surface
not known ever to undergo active endocytosis. The CD8 localization of the CD4–Nef chimera and of CD4 in stably
cytoplasmic domain was thus replaced with Nef, yield- expressing Namalwa cells by immunogold electron mi-
ing the 88Nef fusion protein; a tail-less CD8 variant, 88X, croscopy (Figure 6). Cells were incubated at 48C with
served as control. The ability of 88Nef to down-regulate an anti-CD4 antibody followed by a secondary antibody
CD4 in trans was first tested by transient transfection coupled to colloidal gold. Cells either were or were not
of 293 cells. Closely mimicking the results obtained with
subsequently incubated at 378C for 10 min to allow en-
the CD4–Nef chimera, 88Nef down-modulated CD4 al-
docytosis and then were processed for electron micro-
most as efficiently as myristoylated Nef, whereas it had
scopic analysis. Following a 2 hr incubation at 48C in
no effect on the Nef-resistant CD4LL414AA, in which the the presence of anti-CD4 antibody, about 1% of bothCD4 dileucine motif is mutated (data not shown). Like
CD4 and 44Nef molecules were found associated with44X, 88X did not alter the expression of either marker.
clathrin-coated pits, which occupy approximately 2%Stably transfected Namalwa cell populations were then
of the cell surface. At the end of a 10 min incubation atestablished. In these cells, 88Nef and 88X exhibited pro-
378C, the percentage of gold particles associated withfiles of biosynthesis and maturation comparable with
clathrin-coated pits on the surface of cells expressingthose of their CD4-derived counterparts. Likewise, sur-
CD4 reached 9.5%, whereas with 44Nef it increased toface expression of 88Nef was much lower than that of
19%. Thus, the replacement of the CD4 cytoplasmic88X, and the chimeric molecule underwent markedly
domain by Nef significantly augments the recruitmentaccelerated endocytosis as well as intracellular reten-
of this molecule into clathrin-coated pits.tion (data not shown). The cis effect of Nef is thus inde-
The apparent absence of CD4 and 44Nef withinpendent of any CD4 determinants.
clathrin-coated pits, before warming, could be taken toNef is significantly larger than the normal cytoplasmic
indicate the antibody dependence of the internalizationtail of CD4. To exclude the possibility that this sizediffer-
process. However, the reduced surface half-life of theseence might beresponsible for the acceleratedendocyto-
molecules in the pulse–chase biotinylation assay sug-sis of 44Nef, we generated a stable Namalwa cell popu-
gests other explanations. For instance, it could be thatlation that expressed a chimeric protein (referred to as
CD4 and 44Nef molecules that are already associated44MA) composed of the extracellular and transmem-
with deeply invaginated coated pits are not accessible tobrane domains of CD4, with the matrix protein of HIV
the large antibody probe, similar to what was observedas the cytoplasmic domain (Gallay et al., 1995). 44MA
when using avidin as a probe to examine the coated-pitwas internalized at less than half the rate of 44Nef (data
association of transferrin receptor (Carter et al., 1993).not shown), indicating that a large cytoplasmic tail is not
Alternatively, CD4 and 44Nef molecules that are insufficient to trigger rapid endocytosis. Another concern
coated pits when the first antibody is added could be-was that the high surface expression levels of the CD4-
come internalized during the washing steps performedbased markers other than 44Nef might saturate the en-
docytic capacity of the cell. However, treatment of prior to introducing the secondary antibody.
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Figure 6. Recruitment of a CD4–Nef Chimera
into Clathrin-Coated Pits
Immunogold electron microscopic analysis of
Namalwa cells expressing CD4 (top) or 44Nef
(bottom), using a primary antibody against
CD4 and a secondary antibody labeled with
gold particles. Antibody binding was for 2 hr
at 48C; photographs shown here were taken
after an additional 10 min incubation at
378C. In 44Nef-expressing cells, two clathrin-
coated pits are shown (cp), each containing
several gold particles.
Nef Also Mediates Golgi Retention It could be argued that conclusions based on the
study of chimeric molecules may not accurately reflectin cis and in trans
the events involved in Nef-mediated CD4 trans regula-The pulse–chase biotinylation assay indicated that intra-
tion. However, the CD4–Nef and CD8–Nef fusion pro-cellular retention contributed to the cis-mediated, and
teins retained the ability to down-modulate a CD4-probably also the trans-mediated, down-regulation of
derived target in trans in a dileucine-dependent manner.CD4 by Nef, although it was most obvious in the context
These modified proteins thus conserved all the func-of the CD4–Nef chimera. To confirm this point, we exam-
tional features of myristoylated Nef important for thisined the subcellular localization of CD4 and 44Nef in
effect. Furthermore, accelerated endocytosis and intra-stably expressing Namalwa cells by indirect immunoflu-
cellular retention of the CD4–Nef chimera were also ob-orescence coupled with confocal microscopy using an-
served in 293 fibroblasts, indicating that these phenom-tibodies against CD4 and giantin, a protein anchored to
ena were not cell type specific (data not shown). Finally,the Golgi membrane (Linstedt et al., 1995). Whereas
the same dual mechanism accounted for the cis andwild-type CD4 was concentrated at the plasma mem-
trans effects of Nef.brane (Figure 7A), high levels of the 44Nef chimera
Our results imply that Nef must physically recruit CD4accumulated in a crescent-shaped intracellular com-
and presumably MHC I to down-regulate these recep-partment, which could also be stained with the giantin-
tors. An indirect interaction between Nef and CD4 isspecific antibody, indicating that it represented the
possible, for instance through a factor normally respon-Golgi apparatus (Figure 7B). In nef-expressing Namalwa
sible for recognizing the CD4 cytoplasmic tail via itscells, CD4 was concentrated intracellularly, in a region
dileucine motif. However, in view of the specificity of thethat partly overlapped with the Golgi, yet significantly
Nef effect, a directbinding of Nef to theCD4 cytoplasmicextended outside of this compartment. Taken together
domain seems more likely, even though such an interac-with the results of the biochemical analyses indicating
tion has so far not been conclusively demonstrated inthat Nef directed CD4 to lysosomes, these morphologi-
mammalian cells. CD4–Nef complexes may be unstable,cal data were compatible with an accumulation of the
for instance if sorting is rapidly followed by their dissoci-
receptor in late endosomes.
ation. In insect cells overexpressing Nef and CD4, the
myristoylation-dependent binding of Nef to CD4 was
Discussion observed (Harris and Neil, 1994). In another study, incu-
bation of T cell extracts with a glutathione S-trans-
This work sheds light on the mechanism of Nef-induced ferase–Nef fusion protein allowed for the capture of
CD4 and perhaps MHC I down-regulation by revealing several cellular proteins, including CD4, on a glutathi-
that the HIV-1 protein can act as a physical connector one–Sepharose column (Greenway et al., 1995).
with sorting pathways both in the Golgi and at the Finally, the direct binding of Nef to the membrane-
plasma membrane. The study of chimeric integral mem- proximal CD4 cytoplasmic tail was recently demon-
brane proteins comprising the extracellular and trans- strated in the yeast two-hybrid system (Rossi et al.,
membrane regions of CD4 or CD8 with Nef as their 1996) as well as in vitro by nuclear magnetic resonance
cytoplasmic domain first revealed that these molecules (Grzesiek et al., 1996). Most interestingly, in both set-
could down-regulate CD4 in trans, demonstrating that tings this interaction was dependent on the CD4 dileu-
targeting Nef to membranes through a process distinct cine motif, further suggesting that it was functionally
from myristoylation still allows the viral protein to exert relevant for Nef-induced CD4 down-regulation.
its effect on CD4. Second, the CD4–Nef and CD8–Nef Nef can trigger CD4 internalization both in cis and in
chimeras underwent Golgi retention as well accelerated trans. In addition, the viral protein can also impair the
endocytosis via clathrin-coated pits. Because the CD4– migration of the receptor from the Golgi apparatus to
Nef and CD8–Nef chimeras lacked receptor-derived cy- the cell surface. The latter effect is most pronounced
toplasmic tails, thesedata imply that Nef containsmotifs when Nef is fused to the extracellular and transmem-
capable of interacting with trafficking pathways both in brane domains of CD4 or CD8, suggesting that, nor-
mally, CD4 molecules can at least partly escape Nefthe Golgi and at the plasma membrane.
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Figure 7. Subcellular Localization of CD4 and a CD4–Nef Chimera in Namalwa Cells
Confocal microscopic analysis of Namalwa cells (Na) expressing CD4 (A), 44Nef (B), or CD4 plus Nef (C), performed after staining with
antibodies indicated at the top. The false colors correspond to FITC (green) and Cy3 (red). Bar is 5 mm. The arrow in the right panel of (C)
shows a region subjected to further analysis by volume visualization: shown at the bottom of (C) are 43 enlarged intermediate images of an
animation consisting of a tilted, moving 2 mm thick ZY region of interest moving along the X axis.
action until they reach the cell surface. Several factors the mechanism of Nef-induced CD4 down-regulation,
even though one cannot exclude the possibility thatcould account for this difference. The T lymphocytic
p56lck tyrosine kinase, which binds the CD4 cytoplasmic other as yet unidentified molecules binding to the CD4
cytoplasmic tail might play a role in non-T cells. Alterna-tail in the ER (Crise and Rose, 1992), could play a role
in protecting the receptor from the effect of the viral tively, and perhaps more likely, Nef might interact more
efficiently with CD4 at the plasma membrane, for in-protein. lck prevents CD4 recruitment into clathrin-
coated pits (Pelchen-Matthews et al., 1992, 1993; Sleck- stance because it reaches higher concentrations in this
region of the cell.man et al., 1992), and the displacement of lck from the
CD4 tail precedes Nef-induced CD4 endocytosis (Aiken It is important to note that the dileucine-mutated CD4
variant was completely resistant to the action of Nef,et al., 1994; Rhee and Marsh, 1994). Furthermore, lck
overexpression limits the extent of Nef-induced CD4 indicating that CD4 down-regulation by either intracellu-
lar sequestration or accelerated endocytosis was criti-down-regulation (Goldsmith et al., 1995), suggesting
that lck and Nef compete for access to the CD4 cyto- cally dependent upon the presence of this motif. This
common requirement suggests that Nef acts through aplasmic domain. lck might thus protect CD4 from the
action of Nef until CD4 reaches the cell surface, whereas similar mechanism both in the Golgi and at the plasma
membrane. This is reminiscent of the demonstratedin the absence of the kinase Nef could act at an earlier
time. However, lck is present at low levels in Namalwa involvement of dileucine- and tyrosine-based motifs in
the trafficking of integral membrane proteins at bothcells and absent in 293 fibroblastic cells, and in both
settings the contribution of accelerated endocytosis to levels (Odorizzi et al., 1994; Pond et al., 1995; Rothman
and Wieland, 1996; Trowbridge et al., 1993).Nef-induced CD4 down-regulation is very significant.
This argues against a major role for the kinase in altering Our results indicate that Nef must interact with cellular
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retroviral vectors LnefSN and LXSN as described previously (Aikenfactors normally involved in regulating the sorting of
et al., 1994).integral membrane proteins both in the Golgi and at the
plasma membrane. The binding of Nef to b-COP was
Protein Analyses
demonstrated in the yeast two-hybrid system as well Western blot analyses were performed as described (Aiken et al.,
as in HIV-infected cells (Benichou et al., 1994). Such an 1994) using an ECL kit (Amersham). Rabbit anti-CD4 antibody was
interaction may be relevant for both of these mecha- obtained from the National Institutes of Health AIDS Research and
Reference Reagent Program. Pulse–chase analyses in Namalwanisms of Nef-induced CD4 down-regulation. Indeed,
cells were performed by labeling the cells for 30 min with Tran-b-COP, an essential component of noncoated vesicles
35S label (NEN) at 0.2 mCi/ml in RPMI 1640 lacking cysteine andmediating transport in the ER and Golgi and between the
methionine, followed by washing and incubating the cells in RPMI
cis– and trans–Golgi networks, was recently detected in complete medium. Samples containing5 3 106 cells were withdrawn
endosomes (Aniento et al., 1996; Gruenberg and Max- at intervals and washed in cold PBS. Cytoplasmic proteins were
field, 1995; Whitney et al., 1995). Nevertheless, the extracted using lysis buffer (100 mM Tris [pH 8.0], 100 mM NaCl,
0.5% NP-40, 1 mM PMSF, 10 mg/ml aprotinin, 2 mg/ml leupeptin, 1involvement of b-COP as a mediator of Nef action has
mg/ml pepstatin), and protein concentrations were determined usingyet to be demonstrated. Alternatively, Nef could bind to
the BCAassay (Pierce). Immunoprecipitations wereperformed usinga protein normally involved in recruiting receptors into
protein A/G-Plus–agarose (Santa Cruz Biotech). In brief, 1 mg of
coated vesicles both in the Golgi and at the plasma purified CD4- or CD8-specific antibodies (RPA-T4 and RPA-T8, re-
membrane, such as a component of the so-called adap- spectively) (Pharmingen) was incubated with 20 ml of packed beads
tor complex. Of note, one of these components, in RIPA buffer (50 mM Tris–HCl [pH 7.5], 150 mM NaCl, 1% NP-40,
0.5% sodium deoxycholate, 0.1% SDS), and 150 mg of radiolabeledb-adaptin, presents some homologies with b-COP (Du-
cell lysate was added and incubated at 48C for 12–24 hr. The immuneden et al., 1991; Serafini et al., 1991).
complexes were washed in RIPA buffer and analyzed by SDS–PAGEIn conclusion, this work reveals a novel mechanism
and autoradiography. Recombinant endo H was purchased from
for regulating the cell surface expression of receptor New England Biolabs and used according to the recommendations
molecules, as it suggests that the HIV-1 Nef protein of the manufacturer.
acts by connecting CD4, and probably MHC I, with cell The pulse–chase biotinylation assay was performed using 1 3
107 cells per timepoint, which were labeled and chased as in thesorting pathways. An early protein of myxomaviruses
pulse–chase protocol described above. At each timepoint, cellsalso induces the cell surface down-modulation of CD4
were harvested and washed twice in PBS1 (containing 1 mM MgCl2(Barry et al., 1995). Like Nef, this factor acts indepen-
and 0.1 mM CaCl2). Cell surface proteins were then biotinylated bydently from CD4 phosphorylation, and triggers the dis- treatment with 0.5 mg/ml sulfo-NHS-biotin in PBS1 for 10 min on
sociation of lck and CD4 prior to inducing CD4 degrada- ice. The reaction was quenched by the addition of 1 vol of RPMI.
tion in lysosomes. Whether this reflects altered sorting The cells were then washed twice in PBS1, and cytoplasmic pro-
teins were extracted using lysis buffer. Protein concentrations werefrom the Golgi, the plasma membrane, or both, remains
determined using the BCA assay (Pierce). Immunoprecipitationsto be determined. Similarly, the mechanism by which a
were performed using protein A/G-Plus–agarose (Santa Cruz Bio-protein encoded by the E3 transcriptional unit of human
tech). In brief, 1 mg of purified CD4-specific antibody (RPA-T4; Phar-
group C adenovirus down-modulates the EGF receptor mingen) was incubated with 20 ml of packed beads in RIPA buffer,
is as yet unknown (Carlin et al., 1989; Hoffman et al., and 150 mg of radiolabeled cell lysate was added and incubated at
1992). Further exploration of these questions is likely 48C for 12–24 hr. The immune complexes were washed in RIPA
buffer and boiled in 10% SDS for 5 min to denature the proteins. Ato provide significant insights into pathways normally
fraction of the resulting supernatant was reprecipitated using 20 mlinvolved in the trafficking of cellular proteins.
strepavidin beads (Pierce) in RIPA buffer for 12–24 hr at 48C. The
beads were then washed in RIPA, and the precipitated protein was
analyzed by SDS–PAGE. Gels were fixed by incubation in 30% iso-Experimental Procedures
propyl alcohol, 10% acetic acid for 30 min, followed by a 30 min
incubation in distilled water. The gels were then soaked in fluoro-DNA Constructions
hance (RPI) for 1 hr and dried directly.The HIV-1 nef allele used in these experiments has been described
previously (Aiken et al., 1994). CD4–Nef and CD8–Nef chimeras were
Flow Cytometrycreated by ligating DNA fragments generated by the polymerase
Flow cytometry was performed on a Becton Dickinson FACScanchain reaction. Nef and all surface markers were expressed from
using fluorescein- and R-phycoerythrin-conjugated monoclonal an-the CMV immediate-early promoter, in the pCMX plasmid vector
tibodies against CD4 andCD8 (Pharmingen). Live-dead celldiscrimi-(Umesono et al., 1991).
nation was accomplished by staining with propidium iodide. Data
analyses were performed on a Sun workstation using the software
package SunDisplay 3 (Joe Trotter).Cell Lines and Transfections
The Epstein–Barr virus–transformed Namalwa human B cell line was
cultivated in RPMI 1640 medium supplemented with 10% fetal calf Endocytosis Assays
The FACS-based endocytosis assay (Chambers et al., 1993) usedserum. 293 cells were grown in DMEM supplemented with 10% fetal
calf serum. Transfections of 293 cells were performed using the an R-phycoerythrin-conjugated monoclonal antibody to CD4 (Phar-
mingen). Cells (107) were incubated with the antibody for 30 mincalcium phosphate method (Ausubel et al., 1987). For flow cytome-
tric analysis, transfected 293 cells were removed from the dishes in tissue culture medium containing 10% fetal calf serum at 48C.
Following several washes to remove unbound antibody, total boundby washing once with calcium- and magnesium-free PBS and incu-
bating with 1 mM EDTA. For the establishment of cell populations antibody and background signal were measured by FACS by trans-
ferring 1.5 3 106 cells in 50 ml into a 5-fold excess of PBS or astably producing the various CD4 and CD8 derivatives, Namalwa
cells were coelectroporated with a mixture comprising a CMV-based buffered saline solution at pH 2, respectively. The cells were then
incubated at 378C, and aliquots were removed at various times forplasmid expressing one of these proteins and pSV2-His, at a 1:10
ratio, using a total of 50 mg of DNA for 5 3 106 cells, at a voltage analysis following addition of a 5-fold excess of the acidic saline
solution. The fraction of CD4 internalized was calculated by sub-of 250 V and a capacitance of 960 mF. Cells were then selected
in histidine-deficient medium containing 1 mM histidinol (Sigma). tracting the mean fluorescence of the initial time zero acid wash
from all values and then dividing the acid wash (internalized) meanNamalwa and CEM cell lines expressing Nef were created using the
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fluorescence by the total bound antibody (surface plus internalized) Program for AIDS Research to J.-L. C.; from the Fogarty International
Center to D. T. and J.-L. C.; and by a postdoctoral fellowship frommean fluorescence. Of note, it was previously shown that Fab frag-
ments and divalent antibodies could be interchangeably used to the National Institutes of Health and a scholarship from AMFAR to
C. A. A. M. is a member of the joint University of California, Sanstudy CD4 endocytosis (Pelchen-Matthews et al., 1989, 1991).
Diego Biology Department–Salk Institute graduate program. As a
Pew Scholar in the Biomedical Sciences, D. T. received supportImmunoelectron Microscopy
from the Pew Charitable Trust.Cells were washed and incubated for 2 hr at 48C with Leu3a antibody
(Beckton Dickinson) diluted 1:15 in cold PBS containing 1% BSA.
Received June 13, 1996; revised October 10, 1996.After antibody binding, cells were washed twice by centrifugation
(200 3 g for 5 min) and incubated further with an anti-mouse IgG
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